← Back to patent-cliff list
Chloral Hydrate Syrup(Hainan Pengkang Pharma)
Tier C — Watch / tradeChloral Hydrate Syrup(Hainan Pengkang Pharma)
-
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：催眠, Sedation
Regional status
US
-
EU
-
China
Approved
2024-06-28
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Chloral Hydrate Syrup(Hainan Pengkang Pharma)?
Approved indications include: 催眠, Sedation.
When does the Chloral Hydrate Syrup(Hainan Pengkang Pharma) patent expire?
No public expiry year is available for Chloral Hydrate Syrup(Hainan Pengkang Pharma) yet; this page updates once verified.
How do I get a quote for Chloral Hydrate Syrup(Hainan Pengkang Pharma) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27